Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

42 Pages (Click to Jump) V  « < 39 40 41 42   
 
  
Reply to this topic

STI, STIRLING PRODUCTS LIMITED
JSM
post Posted: Mar 4 2004, 01:05 PM
  Quote Post


Posts: 649
Thanks: 1


Geez, these have been all over the place this week!

Just when they look like going 20-25c they spring back to 35/37c! Nice one to short-term trade perhaps? Shame those options are over-priced.

 
JSM
post Posted: Mar 1 2004, 12:05 PM
  Quote Post


Posts: 649
Thanks: 1


Only 4 buyers left in the market! Crash & Burn?

 
chiller
post Posted: Feb 27 2004, 11:01 AM
  Quote Post


Posts: 4,984
Thanks: 521


Hi Jsm,

Looks like it might be consolidating around the 0.37 mark at the moment but this could go all the way back to 0.25. Wait for awhile but I agree with you jsm could be good long term.

Cheers Chiller



--------------------
Temporary insanity only
 
JSM
post Posted: Feb 27 2004, 10:37 AM
  Quote Post


Posts: 649
Thanks: 1


Been taking a hammering since Weds am. Will be interesting to see where it consolidates, this weeks' publicity is waring off. Looks like it could be interesting as a long term spec buy.

 
cable-guy
post Posted: Feb 25 2004, 09:17 AM
  Quote Post


Posts: 943


nice open , onwards and upwards

 
cloudwalker
post Posted: Feb 24 2004, 07:35 PM
  Quote Post


Posts: 771
Thanks: 4


IN REPLY TO A POST BY haspete, Tue 24/02/04 12:42pm   [READ POST]

Hi Pete,

I agree with you that this company has got some pretty serious potential. The market seems to agree at this stage with a lot of very keen buyers grabbing what is on offer from this so far tightly held stock.
I think once this company filters out into the broader market there could be some substancial price appreciation as punters start to correlate the potential of the STI products with CMQ and it's share price. Bearing in mind of course that CMQ is far more market ready than STI it's not likely we will see a share price of $5 in a hurry. But with the small number of shares and blue sky potential I think .80c to $1.40 is achievable in the short term - see CMQ 2-4 years ago.

For anyone interested in this stock there is an Investor Presentation announcement released by the ASX today, as well as various other announcements on it's relisting.

Happy Profits biggrin.gif

 


cable-guy
post Posted: Feb 24 2004, 03:01 PM
  Quote Post


Posts: 943


IN REPLY TO A POST BY haspete, Tue 24/02/04 12:42pm   [READ POST]

I think this is worth apunt with a stoppy around 40c. nice close on a good run.

 
haspete
post Posted: Feb 24 2004, 12:42 PM
  Quote Post


Posts: 802
Thanks: 4


This is a very intresting one worth a look was formaly WON could have a huge upside considering CMQ IS $5 now it has bought the exclusive worldwide license rights for the intellectual property to the Stirling
compound ST810, a beta agonist animal growth promoter. Stirling Products will be committed to the development and successful commercialisation of the Stirling range of animal growth products (“Stirling products”) that will stem from the active compound ST810. Stirling products are pure animal growth promoters that are proposed as replacement products for antibiotics and steroid hormones currently being used in the animal industry as growth promoters but in the process of being phased out from a number of markets. Stirling products are single enantiomer (isomer) beta-2 agonists and as such are at the leading edge of development within the global animal health and production markets for growth promotion. The Company has secured this opportunity to acquire the license to a patented product in an advanced development stage without having to travel the traditional path of other emerging biotech companies requiring significant research and development funding. The Company will therefore offer a different risk profile from the traditional biotechnology company. The active compound ST810 has a well established safety profile within human pharmacology through a number of years of human administration. It is anticipated that Stirling products will provide the Company with a unique opportunity to become a significant player in the development of growth promoting agents that are safe, effective and efficient feedstock additives in the management of poultry, cattle and swine. Collectively the global market for
animal health is very large and growing. The new Board, management and specialised consultants have significant expertise in biotech research, product development and pharmaceutical commercialisation and are all committed to delivering the promise that Stirling products offer. This Prospectus contains details of the Company’s acquisition of Courage, the Offer and a description of the risks associated with an investment in the Company. Please read it carefully before deciding whether to invest, whilst recognising the inherent risks associated with developing and successfully commercialising new products in the biotechnology market. So what do you think?
Pete

 
 


42 Pages (Click to Jump) V  « < 39 40 41 42

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING